Skip to main content
. 2017 Apr 21;72(11):1505–1512. doi: 10.1093/gerona/glx056

Figure 3.

Figure 3.

Tumor necrosis factor-α levels decreased with allogeneic mesenchymal stem cell (MSC) treatment. Serum levels significantly decreased over 50% at 6 mo after infusion with allogeneic MSCs in both the 100M and 200M groups (100M and 200M p = .0001). *p Values are for within treatment arm versus baseline.